📰 Core Imaging News
Core Imaging News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Core Imaging. Real-time updates on events, politics, business and more.
June 28, 2024
Achieve full type over. Who is John Flannery and herlihy remake one of the biggest industrial giants. The story coming out. Train to a dire new word and with the power grid. If boller has been discovered that can attack rates around the globe. Well tell you about the Malicious Software. Lauren Kevin Durrant lays the Golden State Warriors to claim the nba championship with a victory over lebron james and the Cleveland Cavaliers. All of those highlights for you. Train to either 1 00 a. M. In new y...
November 21, 2023
Ashoka University has entered into a partnership with Carl Zeiss India Bangalore Pvt. Ltd. ZEISS Group to establish a stateofart Core Imaging Facility. Under this partnership the company will provide the university with latest cuttingedge microscopy technology including High Resolution Super Resolution High Content microscopes.
November 20, 2023
New Delhi : Ashoka University has entered into a partnership with Carl Zeiss India (Bangalore) Pvt. Ltd. (ZEISS Group) to establish a state-of-art ‘Core Imaging Facility’. Under this partnership, the company will provide the university with latest cu
March 17, 2023
/PRNewswire/ -- AD Solutions, Incs Best in Business 2022, an award-winning workplace technology provider and the leading Sharp Platinum Dealership with global...
March 8, 2021
Wednesday, March 10 Lecture Time: 12:45 - 13:00 Live Discussion: 17:00 - 17:30 Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE/ENGAGE, Phase 3 Studies of Aducanumab in Patients with Early Alzheimers Disease Session: Aβ Targeting Therapies in AD 2 Saturday, March 13 Lecture Time: 12:45 - 13:00 Live Discussion: 17:30 - 18:00 Evaluation of Aducanumab Efficacy in Early Alzheimers Disease. Session: Aβ Targeting Therapies in AD 2 Saturday, March 13 Lecture Time: 13:00 - ...
March 5, 2021
Eisai Alzheimers Disease Pipeline Research to be Presented at Virtual AD/PD™ 2021, Including Lecanemab (BAN2401) Data - Oral presentations and posters highlighting Eisais investigational novel therapies and immunoassay system being studied for Alzheimers disease and its clinical symptoms - Preliminary analyses evaluating brain amyloid beta reduction with lecanemab to be featured in oral presentation - Virtual symposium: The Science Behind the Aβ Pathway in Alzheimers Disease News provided by...